List view / Grid view
Synthetic biology processes can be useful to therapeutic development, diagnostics and vaccine advancement. Drug Target Review’s Victoria Rees spoke with Dr Jim Collins, Termeer Professor of Medical Engineering & Science at MIT and Founding Core Faculty & Lead, Living Cellular Devices at the Wyss Institute at Harvard University, to explore…
Targeting a deadly bacteria's use of succinate in the lungs could control infection and improve the health of people with cystic fibrosis.
A promising vaccine that clears an HIV-like virus from monkeys is closer to clinical trial human testing.
New research has identified a potential treatment against diabetic eye disease from the RBP3 protein, found in the retina.
Researchers have successfully created a multi-organ in vitro model to test toxicity and efficacy of drugs.
Researchers have identified a novel drug target for the prevention of malaria.
